THCV, CBG, XRD, chromatography, and mass spectrometry
Developing the formulation and manufacturing processes, Creating production schedules , Creating microbial facility maps
Charles studied material science and engineering with a concentration on polymers.
He learned to classify and characterize the chemical makeup of different materials and compounds using analytical techniques such as tensile testing, XRD, chromatography (gas and liquid), mass spectrometry, and particle size analysis.
Charles was the Senior Scientist at a Michigan-based vertically integrated cannabis provider.
He was responsible for the development of the formulation and manufacturing processes associated with new products.
He also supervised the infused product operators by creating production schedules and resolving any issues that arose during manufacturing.
At the cannabis company, Charles greatly expanded his knowledge of and connections in the cannabis industry through various conferences and seminars.
He is extremely passionate about cannabis as a medicine and devotes himself to ensuring the safest possible product is available to the consumer.
Charles hosted a training session on state safety compliance testing for the cannabis company’s social equity program, which allowed minorities and those with minor cannabis convictions to create their own business in the industry.
This included testing topics such as potency, heavy metals, pesticides, microbial, and water activity.
He was very passionate about this program because he finds safety testing very important in the industry and loves sharing his knowledge of the industry with those who are truly excited to learn.
Partnering with the VP, they were able to set up an in-house testing lab for microbial screening.
They had the capabilities to test for STEC, salmonella, aspergillus, total yeast and mold, coliforms, and other microbial flora through both PCR and enumeration techniques.
Charles and the VP used this equipment to create a microbial map of the facility and eliminate potential contamination of products.
Additionally, Charles established and maintained a manufacturing line for encapsulated soft gels with equipment from pharmaceutical vendors.
This involved developing the appropriate formula for the gelatin shell as well as the liquid fill containing the API.
Through help from surfactant vendors, they created a fast-acting, highly bioavailable product in 4 different SKUs of varying cannabinoids (THC, CBD, CBN, and, THCa) and cannabinoid levels.
Charles also began some exploratory work with other cannabinoids such as THCV and CBG.